Table 1. Semiquantitative analysis of S100A2 and ΔNp63 transcript expression in NSCLC patients.

S100A2 or ΔNp63 transcripts were coamplified with a control gene transcript from normal and tumour tissue of NSCLC patients, by cmRT–PCR. Reaction products were run on an Agilent bioanalyser. Peak heights of control and test genes were compared for each patient to generate a semiquantitative value for the fold expression of the test gene transcript in the tumour sample compared to matched normal lung. Red boxes indicate where a patient showed ⩾two-fold expression of the test transcript in the tumour sample compared to normal lung. Black boxes indicate a <two-fold expression and a white box indicates no data for that patient.